SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Jayson Punwani will moderate a discussion on Impact Investing at BIO International Convention 2013 in Chicago.
News | 04. 22. 2013
Jayson Punwani will moderate a discussion on Impact Investing at BIO International Convention 2013 in Chicago.
